| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |